Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages.
about
Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virusMitochondrial DNA depletion and respiratory chain activity in primary human subcutaneous adipocytes treated with nucleoside analogue reverse transcriptase inhibitorsInflammation and adipose tissue macrophages in lipodystrophic mice.Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors.Antiretroviral therapy-induced mitochondrial toxicity: potential mechanisms beyond polymerase-γ inhibition.Is HIV a model of accelerated or accentuated aging?Long-term ritonavir exposure increases fatty acid and glycerol recycling in 3T3-L1 adipocytes as compensatory mechanisms for increased triacylglycerol hydrolysis.Development of a novel self-microemulsifying drug delivery system for reducing HIV protease inhibitor-induced intestinal epithelial barrier dysfunctionEffects of the HIV protease inhibitor ritonavir on GLUT4 knock-out mice.HIV protease inhibitors elicit volume-sensitive Cl- current in cardiac myocytes via mitochondrial ROS.Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue.Human lipodystrophies: genetic and acquired diseases of adipose tissue.HIV protease inhibitors disrupt lipid metabolism by activating endoplasmic reticulum stress and inhibiting autophagy activity in adipocytesEffects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular studyLipodystrophy: pathophysiology and advances in treatmentNew and emerging agents in the management of lipodystrophy in HIV-infected patients.Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected menHIV-1, reactive oxygen species, and vascular complicationsThe HIV-1 protease inhibitor nelfinavir activates PP2 and inhibits MAPK signaling in macrophages: a pathway to reduce inflammation.Mitochondrial DNA content, an inaccurate biomarker of mitochondrial alteration in human immunodeficiency virus-related lipodystrophy.Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio: A Cohort Study.Antiretroviral-related adipocyte dysfunction and lipodystrophy in HIV-infected patients: Alteration of the PPARγ-dependent pathwaysEffects of ritonavir on adipocyte gene expression: evidence for a stress-related responseHIV protease inhibitor lopinavir-induced TNF-alpha and IL-6 expression is coupled to the unfolded protein response and ERK signaling pathways in macrophages.Serum adipokines and HIV viral replication in patients undergoing antiretroviral therapy.HIV protease inhibitors and insulin resistance: lessons from in-vitro, rodent and healthy human volunteer modelsMolecular mechanisms for insulin resistance in treated HIV-infection.Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients.Chronic Effects of Ethanol and/or Darunavir/Ritonavir on U937 Monocytic Cells: Regulation of Cytochrome P450 and Antioxidant Enzymes, Oxidative Stress, and CytotoxicityOxidative mitochondrial DNA damage in peripheral blood mononuclear cells is associated with reduced volumes of hippocampus and subcortical gray matter in chronically HIV-infected patientsPremature and accelerated aging: HIV or HAART?Adipose Tissue in HIV Infection.Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals.Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?Improved adipose tissue function with initiation of protease inhibitor-only ART.Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in LDLR-null mice treated with HIV protease inhibitor ritonavir.Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients.Reciprocal effects of antiretroviral drugs used to treat HIV infection on the fibroblast growth factor-21/β-Klotho system.Metabolic effects of initiating lopinavir/ritonavir-based regimens among young children
P2860
Q26851535-D8BA856D-67CC-405E-A50F-1C9F582C2819Q33558933-148E37AA-5C82-402C-83B7-F00C7EE89206Q33591836-3E507309-A4B3-4307-ABE2-41BAC7D4BF03Q33604765-8129401B-CCEC-4B41-9D7B-5724C0EA2F93Q33784656-FB038035-F25A-40EE-8BC1-EBECA5F40523Q33792651-A5050DE2-AF43-47C0-87F1-A47BCEF21625Q33848305-665D3785-1E25-45D7-BE6F-16E8779D48FFQ33901061-1A0E0594-4439-40B2-9428-1C5353F5EC47Q34299021-AE77D411-B9A0-4255-808F-C97C33CFC821Q34333367-3FF41D33-F254-4B58-8314-8C123668E97CQ34503338-CF78DB6C-D3DE-4075-A175-B58B9CFA98B8Q34620588-E7318962-7DE7-462F-80AE-4D9672109391Q34637857-A7652EA9-F6AC-4BD0-B1E7-22DA98723D13Q35106654-F60CE9CC-E1C0-415B-8D9F-1D025BCACFEFQ35148915-33262C6C-5B0B-4BED-BD71-B5277C9603A1Q35557229-8EAC0BDF-55DA-476D-BDB2-248491DFEDC7Q35587294-27F8DC8A-995C-4D29-87B1-53C6F1377CCAQ36040759-943D3F49-FA33-4F67-8404-ED4E9D16D2D7Q36232217-14A2A383-E766-401D-A5D0-A0CD62BC6F2AQ36593775-C64A2ADA-2CA0-46FD-A129-8231EF114953Q36822866-ABB15173-F266-450C-9B24-941EBA7861D0Q37033675-3E164FA9-4A88-4C4D-AE9F-959A42137CABQ37038292-8F42145C-247E-42CB-8C60-EA2C343F2E1EQ37246875-997CF2DF-ACBC-4E59-A1ED-14CA2C9DC447Q37441523-E6668283-457D-4409-816A-C24C9BD1EFFFQ37447923-EC9F4EA9-93E9-47CB-A7FC-A3BE03877EDFQ37887885-4877C8C6-2237-456C-8461-1B91822664B0Q38734899-AD98FA73-1C9A-48B6-8EB0-7076AAC220C4Q38806803-D3D863C0-BE28-421F-8126-AE0FBB76DC37Q39116610-12A69A82-DFF3-48FF-AF09-11D86141F098Q39474417-F8FDFD1C-6427-4A7C-9E8E-8BBAD08B6C6FQ40038736-5D6201ED-E43D-410E-9CC6-975A42BD1119Q40051820-A20863A7-B252-42F2-B431-75B22EA59229Q40097257-D7F91010-4F1E-45AA-A9AF-BF02C3680F76Q40578427-0705D33A-9D51-4DD0-8FA3-DF15E5F62C6AQ42176233-368AB894-17D2-44DE-B5F0-72E70CB3C644Q43865605-52D083EB-EB3E-4D8F-A3A8-23759575EFADQ45356311-E70A856E-AA68-4837-8E6A-4F37BD045FC3Q52584724-15623913-419B-4F13-B469-957C15366CE0Q57795380-B0DB56F6-FAE5-44AC-81EC-E2CE1D8F30AB
P2860
Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Some HIV antiretrovirals incre ...... an adipocytes and macrophages.
@en
type
label
Some HIV antiretrovirals incre ...... an adipocytes and macrophages.
@en
prefLabel
Some HIV antiretrovirals incre ...... an adipocytes and macrophages.
@en
P2093
P1433
P1476
Some HIV antiretrovirals incre ...... man adipocytes and macrophages
@en
P2093
Brenda Eustace
Claire Lagathu
Dan Frantz
Jacqueline Capeau
Jean-Philippe Bastard
Martine Caron
Matthieu Prot
Michael Briggs
Mustapha Maachi
Stephane Azoulay
P304
P577
2007-01-01T00:00:00Z